Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism GPR88 agonists(G protein-coupled receptor 88 agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 12 Jan 2024 | |
Attention Deficit Disorder With Hyperactivity | Preclinical | US | 12 Jan 2024 | |
Bipolar and Related Disorders | Preclinical | US | 12 Jan 2024 | |
Drug abuse | Preclinical | US | 12 Jan 2024 | |
Huntington Disease-Like Syndrome | Preclinical | US | 12 Jan 2024 | |
Parkinson Disease | Preclinical | US | 12 Jan 2024 | |
Schizophrenia | Preclinical | US | 12 Jan 2024 | |
Tourette Syndrome | Preclinical | US | 12 Jan 2024 |